Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 385 | 20 | 5.2 | 110 | 28.6 | 152 | 39.5 | 79 | 20.5 | 24 | 6.2 |
2015-2019 | 404 | 23 | 5.7 | 112 | 27.7 | 152 | 37.6 | 84 | 20.8 | 33 | 8.2 |
2014-2018 | 389 | 22 | 5.7 | 112 | 28.8 | 138 | 35.5 | 75 | 19.3 | 42 | 10.8 |
2013-2017 | 385 | 19 | 4.9 | 122 | 31.7 | 130 | 33.8 | 70 | 18.2 | 44 | 11.4 |
2012-2016 | 357 | 16 | 4.5 | 115 | 32.2 | 117 | 32.8 | 66 | 18.5 | 43 | 12.0 |
2011-2015 | 317 | 12 | 3.8 | 107 | 33.8 | 101 | 31.9 | 59 | 18.6 | 38 | 12.0 |
2010-2014 | 319 | 11 | 3.4 | 118 | 37.0 | 98 | 30.7 | 58 | 18.2 | 34 | 10.7 |
2009-2013 | 350 | 14 | 4.0 | 127 | 36.3 | 108 | 30.9 | 70 | 20.0 | 31 | 8.9 |
2008-2012 | 365 | 17 | 4.7 | 122 | 33.4 | 119 | 32.6 | 70 | 19.2 | 37 | 10.1 |
2007-2011 | 387 | 17 | 4.4 | 123 | 31.8 | 125 | 32.3 | 70 | 18.1 | 52 | 13.4 |
2006-2010 | 383 | 16 | 4.2 | 120 | 31.3 | 120 | 31.3 | 64 | 16.7 | 63 | 16.4 |
2005-2009 | 385 | 16 | 4.2 | 115 | 29.9 | 127 | 33.0 | 56 | 14.5 | 71 | 18.4 |
2004-2008 | 385 | 14 | 3.6 | 121 | 31.4 | 130 | 33.8 | 53 | 13.8 | 67 | 17.4 |
2003-2007 | 381 | 14 | 3.7 | 118 | 31.0 | 130 | 34.1 | 48 | 12.6 | 71 | 18.6 |
2002-2006 | 392 | 15 | 3.8 | 112 | 28.6 | 143 | 36.5 | 52 | 13.3 | 70 | 17.9 |
2001-2005 | 414 | 17 | 4.1 | 117 | 28.3 | 161 | 38.9 | 55 | 13.3 | 64 | 15.5 |
2000-2004 | 428 | 23 | 5.4 | 118 | 27.6 | 166 | 38.8 | 63 | 14.7 | 58 | 13.6 |
1999-2003 | 421 | 24 | 5.7 | 110 | 26.1 | 167 | 39.7 | 60 | 14.3 | 60 | 14.3 |
1998-2002 | 442 | 22 | 5.0 | 111 | 25.1 | 181 | 41.0 | 73 | 16.5 | 55 | 12.4 |
1997-2001 | 423 | 23 | 5.4 | 111 | 26.2 | 170 | 40.2 | 72 | 17.0 | 47 | 11.1 |
1996-2000 | 428 | 25 | 5.8 | 111 | 25.9 | 163 | 38.1 | 81 | 18.9 | 48 | 11.2 |
1995-1999 | 397 | 20 | 5.0 | 102 | 25.7 | 149 | 37.5 | 76 | 19.1 | 50 | 12.6 |
1994-1998 | 370 | 18 | 4.9 | 92 | 24.9 | 130 | 35.1 | 79 | 21.4 | 51 | 13.8 |
1993-1997 | 330 | 19 | 5.8 | 82 | 24.8 | 111 | 33.6 | 73 | 22.1 | 45 | 13.6 |
1992-1996 | 329 | 16 | 4.9 | 90 | 27.4 | 101 | 30.7 | 71 | 21.6 | 51 | 15.5 |
1991-1995 | 299 | 14 | 4.7 | 78 | 26.1 | 86 | 28.8 | 62 | 20.7 | 59 | 19.7 |
1990-1994 | 319 | 8 | 2.5 | 84 | 26.3 | 91 | 28.5 | 64 | 20.1 | 72 | 22.6 |
1989-1993 | 313 | 8 | 2.6 | 85 | 27.2 | 86 | 27.5 | 57 | 18.2 | 77 | 24.6 |
1988-1992 | 313 | 9 | 2.9 | 75 | 24.0 | 80 | 25.6 | 50 | 16.0 | 99 | 31.6 |
1987-1991 | 271 | 8 | 3.0 | 50 | 18.5 | 71 | 26.2 | 43 | 15.9 | 99 | 36.5 |
1986-1990 | 246 | 6 | 2.4 | 39 | 15.9 | 60 | 24.4 | 37 | 15.0 | 104 | 42.3 |
1985-1989 | 209 | 6 | 2.9 | 23 | 11.0 | 42 | 20.1 | 32 | 15.3 | 106 | 50.7 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |